Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

By
Doug Brunk
February 19, 2026
2 min

Conexiant

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Gastroenterology
- Inflammatory Bowel Disease
- Clinical Research
#2

Cleveland Clinic

Cleveland, OH
Key Differentiators
- Gastroenterology
- Inflammatory Bowel Disease
- Translational Research
#3

Mount Sinai Health System

New York, NY
Key Differentiators
- Gastroenterology
- Inflammatory Bowel Disease
- Epidemiology
#4

University of California, San Francisco (UCSF)

San Francisco, CA
Key Differentiators
- Gastroenterology
- Inflammatory Bowel Disease
- Clinical Trials
#5

Johns Hopkins Medicine

Baltimore, MD
Key Differentiators
- Gastroenterology
- Inflammatory Bowel Disease
- Immunology

Advanced Crohn’s Therapies Show Similar Safety

Top Institutions in Gastroenterology

Mayo Clinic

Cleveland Clinic

Mount Sinai Health System

University of California, San Francisco (UCSF)

Johns Hopkins Medicine

Original Source(s)

Advanced Crohn’s Therapies Show Similar Safety

Related Content

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis

Editorial: Volume II of the Community Series on Gut Microbiota and Immune Interactions in Intestinal Disorders